Press Releases

Filter Releases

Date	Title and Summary	View
Toggle SummaryDec 10, 2012	Onconova Presents Positive Clinical Results for Rigosertib at ASH Meeting Three Trials Demonstrate Safety and Tolerability in Hematological Malignancies	View HTML Onconova Presents Positive Clinical Results for Rigosertib at ASH Meeting 17.3 KB
Toggle SummaryOct 09, 2012	Onconova Appoints Dr. Thomas J. McKearn as President, Research and Development	View HTML Onconova Appoints Dr. Thomas J. McKearn as President, Research and Development 13.5 KB
Toggle SummaryOct 03, 2012	Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD®	View HTML Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® 16.8 KB
Toggle SummarySep 19, 2012	Baxter and Onconova Announce European Licensing Agreement for Anti-Cancer Compound Rigosertib Rigosertib in Late-Stage Studies for MDS and Pancreatic Cancer	View HTML Baxter and Onconova Announce European Licensing Agreement for Anti-Cancer Compound Rigosertib 17.6 KB
Toggle SummaryJun 01, 2012	Onconova Presents Clinical Trial Data for Oral Rigosertib at ASCO Annual Meeting Two Clinical Trials Assessed Oral Safety and Bioavailability	View HTML Onconova Presents Clinical Trial Data for Oral Rigosertib at ASCO Annual Meeting 22.2 KB
Toggle SummaryMay 10, 2012	Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes Complete Phase I Data to be Reported at ASCO 2012 Annual Meeting	View HTML Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes 18.6 KB